Erythropoiesis-stimulating agent (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Erythropoiesis-stimulating agent" in English language version.

refsWebsite

Global rank English rank

13nih.gov

4^th place

11web.archive.org

1^st place

11doi.org

2^nd place

8europa.eu

68^th place

117^th place

4semanticscholar.org

11^th place

8^th place

3bbc.co.uk

8^th place

10^th place

2handle.net

102^nd place

76^th place

2fda.gov

447^th place

338^th place

2cyclingnews.com

949^th place

727^th place

1who.int

195^th place

302^nd place

1drugs.com

399^th place

333^rd place

1choosingwisely.org

7,197^th place

4,379^th place

1aranesp.com

low place

1procrit.com

low place

1probiomed.com.mx

low place

1bleacherreport.com

262^nd place

194^th place

1uzh.ch

3,633^rd place

3,091^st place

1chuv.ch

low place

1usatoday.com

41^st place

34^th place

1economist.com

254^th place

236^th place

1chrisharrisonwriting.com

low place

1books.google.com

3^rd place

1sportsci.org

low place

1bicycling.com

low place

1theaustralian.com.au

965^th place

579^th place

1d3epuodzu3wuis.cloudfront.net

low place

1usadar.org

low place

1archive.org

6^th place

aranesp.com

"Aranesp(darbepoetin alfa)". Amgen.com. Retrieved 2009-04-29.

archive.org

Bauer K (2011). Ride a Stage of the Tour De France The Legendary Climbs and How to Ride Them. London: A & C Black. p. 35. ISBN 978-1-4081-3333-0.

bbc.co.uk

news.bbc.co.uk

"Pantani: Future 'in doubt'". BBC. 5 June 1999. Retrieved 30 June 2011.
"Landis admits to illegal drug use". BBC News. 2010-05-20.

bbc.co.uk

Chapman M (2012-10-15). "Cycling's Dirty Truth". Sport, Peddlers. BBC Radio 5. Archived from the original on October 16, 2012.

bicycling.com

Startt J (2012-10-15). "Christophe Bassons Interview: 'People Now See I Wasn't Lying'". This Just In. Bicycling.com. Archived from the original on 2012-10-18.

bleacherreport.com

"Boxing Scandals". Bleacher Report. December 2011. Retrieved 2011-12-22.

books.google.com

Gifford B (Jan–Feb 2006). "Paging Doctor Ferrari". Bicycling: 50–59.

choosingwisely.org

American Society of Nephrology, "Five Things Physicians and Patients Should Question" (PDF), Choosing Wisely: an initiative of the ABIM Foundation, American Society of Nephrology, archived from the original (PDF) on April 16, 2012, retrieved August 17, 2012

chrisharrisonwriting.com

Harrison C (2003-03-01). "The Man Who Knows Too Much". Sport Monthly. chrisharrisonwriting. Archived from the original on 2014-02-26.

chuv.ch

doping.chuv.ch

History of the Swiss Laboratory for Doping Analyses Archived 2016-03-29 at the Wayback Machine, www.doping.chuv.ch (page visited on 11 June 2014).

cyclingnews.com

autobus.cyclingnews.com

Maloney T (2003). "An Interview With Dr. Michele Ferrari, part two: That l'Equipe Interview". by Jean-Michel Rouet, from l'Equipe, 1994, reprinted excerpt. Cycling News.

cyclingnews.com

Millar R (2003-10-23). "The Bare Minimum". Cycling News.

d3epuodzu3wuis.cloudfront.net

United States Anti Doping Agency. "Report on proceedings under the world anti-doping code and the usada protocol united states anti-doping agency, claimant, v. lance armstrong, respondent. reasoned decision of the united states anti-doping agency" (PDF). USADA. Retrieved 2012-10-28.

doi.org

Tanne JH (2010). "FDA restricts use of erythropoiesis stimulating drugs". BMJ. 340: c1050. doi:10.1136/bmj.c1050. S2CID 72017313.
Aapro MS, Link H (2008). "September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents". The Oncologist. 13: 33–36. doi:10.1634/theoncologist.13-S3-33. PMID 18458123.
Aher SM, Ohlsson A (28 January 2020). "Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants". The Cochrane Database of Systematic Reviews. 1 (1): CD004868. doi:10.1002/14651858.CD004868.pub6. PMC 6986694. PMID 31990982.
Kaufner L, Heymann C (2020). "Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery". Cochrane Database of Systematic Reviews. 2020 (8): CD012451. doi:10.1002/14651858.CD012451.pub2. PMC 8095002. PMID 32790892.
Chung EY, Palmer SC, Saglimbene VM, Craig JC, Tonelli M, Strippoli GF (February 2023). "Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis". The Cochrane Database of Systematic Reviews. 2023 (2): CD010590. doi:10.1002/14651858.CD010590.pub3. PMC 9924302. PMID 36791280.
Jelkmann W, Lundby C (Sep 2011). "Blood doping and its detection" (PDF). Blood. 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Lasne F, Martin L, Crepin N, de Ceaurriz J (Dec 2002). "Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones". Analytical Biochemistry. 311 (2): 119–26. doi:10.1016/S0003-2697(02)00407-4. PMID 12470670.
Kohler M, Ayotte C, Desharnais P, Flenker U, Lüdke S, Thevis M, Völker-Schänzer E, Schänzer W (Jan 2008). "Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels". International Journal of Sports Medicine. 29 (1): 1–6. doi:10.1055/s-2007-989369. PMID 18050057. S2CID 11677786.
Jelkmann W (2012). "The disparate roles of cobalt in erythropoiesis, and doping relevance". Open Journal of Hematology. 3: 3–6. doi:10.13055/ojhmt_3_1_6.121211.
Lodewijkx HF, Brouwer B (Dec 2011). "Some empirical notes on the epo epidemic in professional cycling". Research Quarterly for Exercise and Sport. 82 (4): 740–54. doi:10.1080/02701367.2011.10599811. PMID 22276416. S2CID 34350476.
Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, Calbet JA (Aug 2008). "Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?". Journal of Applied Physiology. 105 (2): 581–7. doi:10.1152/japplphysiol.90484.2008. hdl:10553/6534. PMID 18535134.

drugs.com

"Epoetin alfa Use During Pregnancy | Drugs.com". Drugs.com. Retrieved 13 December 2017.

economist.com

"Breathe it in". The Economist. 8 February 2014.

europa.eu

ema.europa.eu

"Aranesp EPAR". European Medicines Agency (EMA). 13 January 2020. Retrieved 10 March 2020.
"Binocrit EPAR". European Medicines Agency (EMA). 31 October 2019. Retrieved 10 March 2020.
"Abseamed EPAR". European Medicines Agency (EMA). 8 October 2019. Retrieved 10 March 2020.
"Mircera EPAR". European Medicines Agency (EMA). 20 December 2019. Retrieved 10 March 2020.
"Dynepo EPAR". European Medicines Agency (EMA). 23 April 2009. Retrieved 10 March 2020.
"Silapo EPAR". European Medicines Agency (EMA). 10 March 2020. Retrieved 10 March 2020.
"Retacrit EPAR". European Medicines Agency (EMA). 14 January 2020. Retrieved 10 March 2020.
Wathion N. "Public statement on Dynepo (epoetin delta)" (PDF). European Medicines Agency. Archived from the original (PDF) on 24 September 2015. Retrieved 31 August 2015.

fda.gov

"Information on Erythropoiesis-Stimulating Agents (ESA) Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp)". US Food and Drug Administration – Drug Safety Information. 31 March 2017. Archived from the original on 14 April 2022.

accessdata.fda.gov

"Highlights of Prescribing Information" (PDF). FDA. Retrieved 13 December 2017.

handle.net

hdl.handle.net

World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, Calbet JA (Aug 2008). "Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?". Journal of Applied Physiology. 105 (2): 581–7. doi:10.1152/japplphysiol.90484.2008. hdl:10553/6534. PMID 18535134.

nih.gov

pubmed.ncbi.nlm.nih.gov

Aapro MS, Link H (2008). "September 2007 Update on EORTC Guidelines and Anemia Management with Erythropoiesis-Stimulating Agents". The Oncologist. 13: 33–36. doi:10.1634/theoncologist.13-S3-33. PMID 18458123.
Aher SM, Ohlsson A (28 January 2020). "Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants". The Cochrane Database of Systematic Reviews. 1 (1): CD004868. doi:10.1002/14651858.CD004868.pub6. PMC 6986694. PMID 31990982.
Kaufner L, Heymann C (2020). "Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery". Cochrane Database of Systematic Reviews. 2020 (8): CD012451. doi:10.1002/14651858.CD012451.pub2. PMC 8095002. PMID 32790892.
Chung EY, Palmer SC, Saglimbene VM, Craig JC, Tonelli M, Strippoli GF (February 2023). "Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis". The Cochrane Database of Systematic Reviews. 2023 (2): CD010590. doi:10.1002/14651858.CD010590.pub3. PMC 9924302. PMID 36791280.
Macdougall IC (Jul 2000). "Novel erythropoiesis stimulating protein". Seminars in Nephrology. 20 (4): 375–81. PMID 10928340.
Jelkmann W, Lundby C (Sep 2011). "Blood doping and its detection" (PDF). Blood. 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Lasne F, Martin L, Crepin N, de Ceaurriz J (Dec 2002). "Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones". Analytical Biochemistry. 311 (2): 119–26. doi:10.1016/S0003-2697(02)00407-4. PMID 12470670.
Kohler M, Ayotte C, Desharnais P, Flenker U, Lüdke S, Thevis M, Völker-Schänzer E, Schänzer W (Jan 2008). "Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels". International Journal of Sports Medicine. 29 (1): 1–6. doi:10.1055/s-2007-989369. PMID 18050057. S2CID 11677786.
Lodewijkx HF, Brouwer B (Dec 2011). "Some empirical notes on the epo epidemic in professional cycling". Research Quarterly for Exercise and Sport. 82 (4): 740–54. doi:10.1080/02701367.2011.10599811. PMID 22276416. S2CID 34350476.
Lundby C, Robach P, Boushel R, Thomsen JJ, Rasmussen P, Koskolou M, Calbet JA (Aug 2008). "Does recombinant human Epo increase exercise capacity by means other than augmenting oxygen transport?". Journal of Applied Physiology. 105 (2): 581–7. doi:10.1152/japplphysiol.90484.2008. hdl:10553/6534. PMID 18535134.

ncbi.nlm.nih.gov

Aher SM, Ohlsson A (28 January 2020). "Late erythropoiesis-stimulating agents to prevent red blood cell transfusion in preterm or low birth weight infants". The Cochrane Database of Systematic Reviews. 1 (1): CD004868. doi:10.1002/14651858.CD004868.pub6. PMC 6986694. PMID 31990982.
Kaufner L, Heymann C (2020). "Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery". Cochrane Database of Systematic Reviews. 2020 (8): CD012451. doi:10.1002/14651858.CD012451.pub2. PMC 8095002. PMID 32790892.
Chung EY, Palmer SC, Saglimbene VM, Craig JC, Tonelli M, Strippoli GF (February 2023). "Erythropoiesis-stimulating agents for anaemia in adults with chronic kidney disease: a network meta-analysis". The Cochrane Database of Systematic Reviews. 2023 (2): CD010590. doi:10.1002/14651858.CD010590.pub3. PMC 9924302. PMID 36791280.

probiomed.com.mx

"Probiomed". probiomed.com.mx. Archived from the original on 2018-03-26. Retrieved 2018-03-21.

procrit.com

"Procrit (Epoetin alfa)". Ortho Biotech Products. Archived from the original on 2009-10-26. Retrieved 2009-04-29.

semanticscholar.org

api.semanticscholar.org

Tanne JH (2010). "FDA restricts use of erythropoiesis stimulating drugs". BMJ. 340: c1050. doi:10.1136/bmj.c1050. S2CID 72017313.
Jelkmann W, Lundby C (Sep 2011). "Blood doping and its detection" (PDF). Blood. 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.
Kohler M, Ayotte C, Desharnais P, Flenker U, Lüdke S, Thevis M, Völker-Schänzer E, Schänzer W (Jan 2008). "Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels". International Journal of Sports Medicine. 29 (1): 1–6. doi:10.1055/s-2007-989369. PMID 18050057. S2CID 11677786.
Lodewijkx HF, Brouwer B (Dec 2011). "Some empirical notes on the epo epidemic in professional cycling". Research Quarterly for Exercise and Sport. 82 (4): 740–54. doi:10.1080/02701367.2011.10599811. PMID 22276416. S2CID 34350476.

sportsci.org

Martin DT, Ashenden M, Parisotto R, Pyne D, Hahn AG (March–April 1997). "Blood testing for professional cyclists: What's a fair hematocrit limit?". Sports Science.

theaustralian.com.au

"Stuart O'Grady admits to doping at 1998 Tour de France". Theaustralian.com.au. 2013-07-25. Retrieved 2013-07-25.

usadar.org

cyclinginvestigation.usadar.org

"U.S. Postal Service Pro Cycling Team Investigation". Statement From USADA CEO Travis T. Tygart Regarding The U.S. Postal Service Pro Cycling Team Doping Conspiracy. USADA. 2012-10-10.^{[permanent dead link‍]}

usatoday.com

Steeg JL (2007-02-28). "Catlin has made a career out of busting juicers – USATODAY.com". USA Today. Retrieved 2009-03-31.

uzh.ch

zora.uzh.ch

Jelkmann W, Lundby C (Sep 2011). "Blood doping and its detection" (PDF). Blood. 118 (9): 2395–404. doi:10.1182/blood-2011-02-303271. PMID 21652677. S2CID 2685044.

web.archive.org

"Information on Erythropoiesis-Stimulating Agents (ESA) Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp)". US Food and Drug Administration – Drug Safety Information. 31 March 2017. Archived from the original on 14 April 2022.
Banzi R, Gerardi C (23 December 2016). WHO EML 2016-2017 - Application for erythropoietin-stimulating agents (erythropoietin type blood factors) (PDF) (Report). WHO. WHO EML 2016–2017, Version 3. Archived from the original (PDF) on 31 August 2020.
American Society of Nephrology, "Five Things Physicians and Patients Should Question" (PDF), Choosing Wisely: an initiative of the ABIM Foundation, American Society of Nephrology, archived from the original (PDF) on April 16, 2012, retrieved August 17, 2012
"Procrit (Epoetin alfa)". Ortho Biotech Products. Archived from the original on 2009-10-26. Retrieved 2009-04-29.
"Probiomed". probiomed.com.mx. Archived from the original on 2018-03-26. Retrieved 2018-03-21.
History of the Swiss Laboratory for Doping Analyses Archived 2016-03-29 at the Wayback Machine, www.doping.chuv.ch (page visited on 11 June 2014).
"FDA Reports New Risks Posed by Anemia Drugs" Associated Press story in The Washington Post (August 8, 2012)
Harrison C (2003-03-01). "The Man Who Knows Too Much". Sport Monthly. chrisharrisonwriting. Archived from the original on 2014-02-26.
Startt J (2012-10-15). "Christophe Bassons Interview: 'People Now See I Wasn't Lying'". This Just In. Bicycling.com. Archived from the original on 2012-10-18.
Chapman M (2012-10-15). "Cycling's Dirty Truth". Sport, Peddlers. BBC Radio 5. Archived from the original on October 16, 2012.
Wathion N. "Public statement on Dynepo (epoetin delta)" (PDF). European Medicines Agency. Archived from the original (PDF) on 24 September 2015. Retrieved 31 August 2015.

who.int

Banzi R, Gerardi C (23 December 2016). WHO EML 2016-2017 - Application for erythropoietin-stimulating agents (erythropoietin type blood factors) (PDF) (Report). WHO. WHO EML 2016–2017, Version 3. Archived from the original (PDF) on 31 August 2020.